JP2011515490A5 - - Google Patents

Download PDF

Info

Publication number
JP2011515490A5
JP2011515490A5 JP2011502032A JP2011502032A JP2011515490A5 JP 2011515490 A5 JP2011515490 A5 JP 2011515490A5 JP 2011502032 A JP2011502032 A JP 2011502032A JP 2011502032 A JP2011502032 A JP 2011502032A JP 2011515490 A5 JP2011515490 A5 JP 2011515490A5
Authority
JP
Japan
Prior art keywords
vaccine
cldc
adjuvanted
fish
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011502032A
Other languages
English (en)
Japanese (ja)
Other versions
JP5759890B2 (ja
JP2011515490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/038307 external-priority patent/WO2009120811A1/en
Publication of JP2011515490A publication Critical patent/JP2011515490A/ja
Publication of JP2011515490A5 publication Critical patent/JP2011515490A5/ja
Application granted granted Critical
Publication of JP5759890B2 publication Critical patent/JP5759890B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011502032A 2008-03-25 2009-03-25 カチオン性脂質−dna複合体(cldc)の投与による免疫応答の増強 Expired - Fee Related JP5759890B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3938108P 2008-03-25 2008-03-25
US61/039,381 2008-03-25
PCT/US2009/038307 WO2009120811A1 (en) 2008-03-25 2009-03-25 Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)

Publications (3)

Publication Number Publication Date
JP2011515490A JP2011515490A (ja) 2011-05-19
JP2011515490A5 true JP2011515490A5 (https=) 2012-05-17
JP5759890B2 JP5759890B2 (ja) 2015-08-05

Family

ID=40791017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011502032A Expired - Fee Related JP5759890B2 (ja) 2008-03-25 2009-03-25 カチオン性脂質−dna複合体(cldc)の投与による免疫応答の増強

Country Status (6)

Country Link
US (1) US8945590B2 (https=)
EP (1) EP2257306B1 (https=)
JP (1) JP5759890B2 (https=)
BR (1) BRPI0910036B8 (https=)
CA (1) CA2719614C (https=)
WO (1) WO2009120811A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2257306B1 (en) 2008-03-25 2014-05-07 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
BRPI1010803A2 (pt) * 2009-05-14 2018-06-12 Bayer Animal Health Gmbh "resposta imune aumentada na espécie aviária"
WO2011106607A2 (en) * 2010-02-26 2011-09-01 Juvaris Biotherapeutics, Inc. Subunit vaccines for herpes viruses and methods of use
UY33821A (es) 2010-12-22 2012-07-31 Bayer Animal Health Gmbh Respuesta inmune potenciada en la especie bovina
CN105579582A (zh) 2013-07-25 2016-05-11 埃克西奎雷股份有限公司 用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体
EP3110940A1 (en) 2014-02-28 2017-01-04 Bayer Animal Health GmbH Immunostimulatory plasmids
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
EP3328423B1 (en) * 2015-07-31 2021-05-26 Bayer Animal Health GmbH Enhanced immune response in fish
AU2016302436B2 (en) 2015-07-31 2022-03-03 Elanco Animal Health Gmbh Enhanced immune response in porcine species
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
EP3533463A4 (en) * 2016-10-31 2020-06-17 Eyegene Inc. IMMUNE REACTION REGULATING SUBSTANCE AND VACCINE COMPOSITION THEREFOR
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US6121247A (en) 1996-03-29 2000-09-19 The Johns Hopkins University Therapy for allergic diseases
EP1006999A2 (en) * 1997-07-08 2000-06-14 Chiron Corporation Use of submicron oil-in-water emulsions with dna vaccines
DK1009413T3 (da) 1997-09-05 2007-06-11 Univ California Anvendelse af immunstimulerende oligonukleotider til forebyggelse eller behandling af astma
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20040247662A1 (en) 1998-06-25 2004-12-09 Dow Steven W. Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US20050013812A1 (en) * 2003-07-14 2005-01-20 Dow Steven W. Vaccines using pattern recognition receptor-ligand:lipid complexes
US20050181035A1 (en) * 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
US20090208781A1 (en) * 2008-02-19 2009-08-20 Skinner George A Method for operating a fuel cell system
EP2249843A4 (en) 2008-02-24 2013-05-08 Us Gov Health & Human Serv USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF INFECTIONS BY DISEASES
EP2257306B1 (en) 2008-03-25 2014-05-07 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
US20100137235A1 (en) 2008-10-15 2010-06-03 Mutual Pharmaceutical Company, Inc. Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics
BRPI1010803A2 (pt) 2009-05-14 2018-06-12 Bayer Animal Health Gmbh "resposta imune aumentada na espécie aviária"

Similar Documents

Publication Publication Date Title
JP2011515490A5 (https=)
Haq et al. Immunosenescence: influenza vaccination and the elderly
EP2257306B1 (en) Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
EP2720717B1 (en) Vaccine adjuvant composition comprising inulin particles
US8216595B2 (en) Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant
RU2020117033A (ru) Комплекс, содержащий олигонуклеотид, обладающий иммуностимулирующей активностью, и его применение
JP2009539965A5 (https=)
Riese et al. Vaccine adjuvants: key tools for innovative vaccine design
JP2009511084A5 (https=)
JP2016506416A5 (https=)
JP2004527264A5 (https=)
RU2008119501A (ru) Функциональные вирусоподоюные частицы гриппа (vlps)
JP2010537961A5 (https=)
Lee et al. Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use
JP2010520284A5 (https=)
JP2013522231A5 (https=)
JP2019510064A5 (https=)
JP7618632B2 (ja) 経鼻b型肝炎ワクチン組成物およびその製造方法
JP2016520077A5 (https=)
AU2006322073A1 (en) dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
KR102654379B1 (ko) 신규한 핵산을 기반으로 하는 인플루엔자 백신 조성물
RU2018103757A (ru) Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита
CN115698295A (zh) 一种疫苗试剂和接种方法
US20130039973A1 (en) Viral Immunogenic Compositions
ES2615120T3 (es) Adyuvantes peptídicos